Vianova Health, Inc. – Trademark Portfolio
Entity Type: 03
Vianova Health, Inc. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 2 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include RITA and VIANOVA HEALTH. The owner is based in McLean, VA.
6th Floor
1751 Pinnacle Drive
McLean, VA 22102
Showing of trademarks Trademarks
Trademark Classifications
Vianova Health, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Vianova Health, Inc. have?
Vianova Health, Inc. has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned.
What trademark classes does Vianova Health, Inc. file in?
Vianova Health, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 44 (Medical Services), Class 42 (Computer & Scientific). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Vianova Health, Inc.'s most well-known trademarks?
Vianova Health, Inc.'s registered trademark portfolio includes well-known marks such as RITA and VIANOVA HEALTH. These are among 2 currently registered trademarks in the portfolio.
What is Vianova Health, Inc.'s trademark registration success rate?
Vianova Health, Inc. has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.